A Pan-cancer Landscape of Interactions between Solid Tumors and Infiltrating Immune Cell Populations

被引:219
|
作者
Tamborero, David [1 ,2 ]
Rubio-Perez, Carlota [1 ,2 ]
Muinos, Ferran [2 ]
Sabarinathan, Radhakrishnan [2 ]
Piulats, Josep M. [3 ]
Muntasell, Aura [4 ]
Dienstmann, Rodrigo [5 ,6 ]
Lopez-Bigas, Nuria [1 ,2 ,7 ]
Gonzalez-Perez, Abel [1 ,2 ]
机构
[1] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona 08002, Spain
[2] Barcelona Inst Sci & Technol, Inst Res Biomed, Barcelona 08028, Spain
[3] CIBERONC, Dept Med Oncol, Inst Catala Oncol IDIBELL, Barcelona, Spain
[4] Hosp del Mar, Res Inst, Barcelona, Spain
[5] Vali dHebron Inst Oncol, Barcelona, Spain
[6] Sage Bionetworks, Seattle, WA USA
[7] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain
基金
欧洲研究理事会; 美国国家卫生研究院;
关键词
METASTATIC MELANOMA; ACQUIRED-RESISTANCE; TGF-BETA; IMMUNOTHERAPY; MICROENVIRONMENT; BLOCKADE; THERAPY; RESPONSES; EVASION; REVEAL;
D O I
10.1158/1078-0432.CCR-17-3509
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Throughout their development, tumors are challenged by the immune system, and they acquire features to evade its surveillance. A systematic view of these traits, which shed light on how tumors respond to immunotherapies, is still lacking. Experimental Design: Here, we computed the relative abundance of an array of immune cell populations to measure the immune infiltration pattern of 9,174 tumors of 29 solid cancers. We then clustered tumors with similar infiltration pattern to define immunophenotypes. Finally, we identified genomic and transcriptomic traits associated to these immunophenotypes across cancer types. Results: In highly cytotoxic immunophenotypes, we found tumors with low clonal heterogeneity enriched for alterations of genes involved in epigenetic regulation, ubiquitin-mediated proteolysis, antigen presentation, and cell-cell communication, which may drive resistance in combination with the ectopic expression of negative immune checkpoints. Tumors with immunophenotypes of intermediate cytotoxicity are characterized by an upregulation of processes involved in neighboring tissue invasion and remodeling that may foster the recruitment of immunosuppressive cells. Tumors with poorly cytotoxic immunophenotype tend to be of more advanced stages and bear a greater burden of copy number alterations and frequent alterations of cell cycle, hedgehog, beta-catenin, and TGF-beta pathways, which may cause immune depletion. Conclusions: We provide a comprehensive landscape of the characteristics of solid tumors that may influence (or be influenced by) the characteristics of their immune infiltrate. These results may help interpret the response of solid tumors to immunotherapies and guide the development of novel drug combination strategies. (C) 2018 AACR.
引用
收藏
页码:3717 / 3728
页数:12
相关论文
共 50 条
  • [31] A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
    Cheng, Sijin
    Li, Ziyi
    Gao, Ranran
    Xing, Baocai
    Gao, Yunong
    Yang, Yu
    Qin, Shishang
    Zhang, Lei
    Ouyang, Hanqiang
    Du, Peng
    Jiang, Liang
    Zhang, Bin
    Yang, Yue
    Wang, Xiliang
    Ren, Xianwen
    Bei, Jin-Xin
    Hu, Xueda
    Bu, Zhaode
    Ji, Jiafu
    Zhang, Zemin
    CELL, 2021, 184 (03) : 792 - +
  • [32] A single-cell pan-cancer analysis to show the variability of tumor-infiltrating myeloid cells in immune checkpoint blockade
    Li, Weiyuan
    Pan, Lu
    Hong, Weifeng
    Ginhoux, Florent
    Zhang, Xuan
    Xiao, Chunjie
    Li, Xuexin
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [33] The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response
    Wang, Guangyu
    Xu, Dandan
    Zhang, Zicheng
    Li, Xinhui
    Shi, Jiaqi
    Sun, Jie
    Liu, Huan-Zhong
    Li, Xiaobo
    Zhou, Meng
    Zheng, Tongsen
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [34] The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response
    Guangyu Wang
    Dandan Xu
    Zicheng Zhang
    Xinhui Li
    Jiaqi Shi
    Jie Sun
    Huan-Zhong Liu
    Xiaobo Li
    Meng Zhou
    Tongsen Zheng
    npj Precision Oncology, 5
  • [35] The Landscape of Tumor Fusion Neoantigens: A Pan-Cancer Analysis
    Wei, Zhiting
    Zhou, Chi
    Zhang, Zhanbing
    Guan, Ming
    Zhang, Chao
    Liu, Zhongmin
    Liu, Qi
    ISCIENCE, 2019, 21 : 249 - +
  • [36] Pan-cancer proteogenomics expands the landscape of therapeutic targets
    Savage, Sara R.
    Yi, Xinpei
    Lei, Jonathan T.
    Wen, Bo
    Zhao, Hongwei
    Liao, Yuxing
    Jaehnig, Eric J.
    Somes, Lauren K.
    Shafer, Paul W.
    Lee, Tobie D.
    Fu, Zile
    Dou, Yongchao
    Shi, Zhiao
    Gao, Daming
    Hoyos, Valentina
    Gao, Qiang
    Zhang, Bing
    CELL, 2024, 187 (16)
  • [37] Pan-cancer proteogenomics expands the landscape of therapeutic targets
    Lei, Jonathan T.
    Savage, Sara R.
    Yi, Xinpei
    Wen, Bo
    Zhao, Hongwei
    Somes, Lauren K.
    Shafer, Paul W.
    Dou, Yongchao
    Gao, Qiang
    Hoyos, Valentina
    Zhang, Bing
    CANCER RESEARCH, 2023, 83 (07)
  • [38] Pan-Cancer Biomarkers Changing the Landscape of Molecular Testing
    Yao, Jinjuan
    Arcila, Maria E.
    Ladanyi, Marc
    Hechtman, Jaclyn F.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (06) : 692 - 698
  • [39] Prediction model for hyperprogressive disease in patients with advanced solid tumors received immune-checkpoint inhibitors: a pan-cancer study
    Yaping Long
    Wenyu Yang
    Yibing Bai
    Haitao Tao
    Fan Zhang
    Lijie Wang
    Bo Yang
    Di Huang
    Xiao Han
    Yi Hu
    Cancer Cell International, 23
  • [40] Pan-cancer analysis reveals the relationship between RCSD1 immune infiltration and clinical prognosis in human tumors
    Qiao, Han
    Yin, Hong
    Feng, Yan
    Tang, Huaping
    FRONTIERS IN IMMUNOLOGY, 2022, 13